Greetings readers!  Today, the goal is to update you on some very exciting data that was recently presented at ESMO, the European Society of Medical Oncology Annual Meeting. In a nutshell, early results from a trial using a type of immune therapy called engineered T cells specific for a protein called MAGE-A4 led to significant tumor shrinkage in patients with … Continue reading Shining the Spotlight on Synovial Sarcoma…